GLEMONT TRADE DATA ANALYSIS
Analyze Glemont export import data and locate key markets, reliable suppliers, and active buyers by utilizing Eximpedia's data-centric platform.Whether you're a supplier looking for high-demand markets or a buyer sourcing apples from reliable exporters, Eximpedia’s data-driven approach for making informed trade decisions.
GLEMONT – Overview
Eximpedia analyses Glemont export import records, including data from 41 buyers and 12 suppliers. We provide an intelligence report of Apple that covers trade statistics, shipment values, quantities, exporters & importers, trade destinations, and HS codes.
Glemont Buyers, Suppliers & Shipments
Products Glemont import markets
Gain insights into Product Glemont with data on monthly import values, major importing countries, key ports, leading competitors, and active suppliers.
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3004900000 | 1.44 | 6 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049000000 | 0.54 | 15 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049090 | 0.37 | 13 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004902900 | 0.15 | 6 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004900002 | 0.11 | 2 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| INDIA | 2.72 | 53 | 0.00 |
| TAIWAN, PROVINCE OF CHINA | 0.01 | 2 | 0.00 |
| THAILAND | 0.00 | 1 | 0.00 |
| IN, INDIA | 0.00 | 1 | 0.00 |
| KH, CAMBODIA | 0.00 | 1 | 0.00 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| HO CHI MINH CITY | 0.07 | 6 | 0.00 |
| UA100200 | 1.44 | 6 | 0.00 |
| BINH DUONG | 0.04 | 5 | 0.00 |
| GUAYAQUIL MARITIMO | 0.07 | 5 | 0.00 |
| AEROPUERTO COM. A. MERINO B | 0.01 | 3 | 0.00 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| ABACUS PHARMA AFRICA LIMITED | 0.54 | 676 |
| GLENMARK IMPEX LLC | 0.11 | 204 |
| GLENMARK PHARMACEUTICALS ECUADOR S A | 0.09 | 9 |
| LLC GLENMARK | 1.44 | 1 |
| HEMAS PHARMACEUTICALS PRIVATE LIMITED | 0.37 | 474 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|
Discover the Hidden Opportunities in HS Code Glemont—access key decision-makers and detailed reports to save time and succeed.
Glemont Import Market
Explore Product Glemont with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30049000000 | INVOICE NO:F22500002965 GLEMONT L 7 UG |  |
|
INDIA | UGANDA | 234 |
| 30049000000 | INVOICE NO:F22500002965 GLEMONT L 7 UG | |
|
INDIA | UGANDA | 234 |
| 30049000000 | INVOICE NO:F22500000020 GLEMONT 5MG TABLETS UG | |
|
INDIA | UGANDA | 160 |
| 30049000000 | ASCORIL LS 100ML UG/GLEMONT L 7'S UG | |
|
INDIA | UGANDA | 934 |
| 30049000000 | INVOICE NO:F22500002965 GLEMONT L 7 UG | |
|
INDIA | UGANDA | 234 |
| 30049000000 | INVOICE NO:F22500000020 GLEMONT 5MG TABLETS UG | |
|
INDIA | UGANDA | 160 |
| 30049000000 | GLEMONT L 7S UG (INCL FREE PHYSICIAN SAMPLES | |
|
INDIA | UGANDA | 136.5 |
| 300680 | PHARMACEUTICALS DERIVA GEL 30GM GLEMONT - L T | |
|
IN, INDIA | USA | 12 |
| 30049090 | MEDICAMENTS - GLEMONT IR 10 , GLENCENT 5MGFLUSORT 50 , GLEMONT CT 4 , GLEMONT C | |
|
INDIA | SRILANKA | 437.36 |
| 30049090 | MEDICAMENTS - FLUSORT 50MCG NASAL SPRAY ,GLEMONT CT 4MG / GLEMONT CT 5MG /,GLEMONT IR 10MG / GLENCET 5MG TABS | |
|
INDIA | SRILANKA | 236.8 |
| 3004900000 | 1. HUMAN MEDICINES FOR THERAPEUTIC USE, PACKAGED FOR RETAIL TRADE: ASCORIL, TABLETS, 10 TABLETS IN BLISTERS; 2 BLISTERS IN A CARTON PACKAGING (ACTIVE INGREDIENTS - 1 TABLET CONTAINS SALBUTAMOL SULFATE EQUIVALENT TO SALBUTAMOL 2 MG, BROMHEXINE HYDROCHLORIDE 8 MG, GUAIFENEZIN 100 MG) SERIES 10232611 - 24 108UP. SERIES 10232622 - 24 136 UNITS SERIES 10232610 - 24 164 UNITS GLEMONT CHEWABLE TABLETS , 4 MG CHEWABLE TABLETS; 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 TABLET CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 4 MG) SERIES 05231029 - 3 020UP. CANDID, SOLUTION FOR THE ORAL CAVITY 1% OF 15 ML IN A VIAL WITH A STOPPER-DROPPER AND CAP WITH FIRST OPENING CONTROL; 1 VIAL IN A CARTON PACKAGING (ACTIVE INGREDIENTS - 1 ML OF SOLUTION CONTAINS CLOTRIMAZOLE 10 MG) SERIES 10232309- 32 280 UP. TRADEMARK: GLENMARK COUNTRY OF MANUFACTURE: IN MANUFACTURER: GLENMARK PHARMACEUTICALS LTD | |
|
INDIA | UKRAINE | 0 |
| 3004900000 | 1. HUMAN MEDICINES FOR THERAPEUTIC USE, PACKAGED FOR RETAIL: GLEMONT, FILM-COATED TABLETS, 10 MG, 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX ( ACTIVE INGREDIENTS: 1 FILM-COATED TABLET , CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 10 MG) SERIES 19240188 - 13 880UP.GLENZET ADVANCE, FILM-COATED TABLETS, 14 TABLETS IN A CONTAINER, 1 CONTAINER IN A CARTON AND BOXES (ACTIVE INGREDIENTS - 1 FILM-COATED TABLET CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 10 MG, LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG) SERIES 05240279 - 16 760UP.GLENCET ADVANCE, FILM-COATED TABLETS, 28 TABLETS IN A CONTAINER, IN 1 CONTAINER CARTON (ACTIVE INGREDIENTS - 1 FILM-COATED TABLET CONTAINS MONTELUCAST SODIUM EQUIVALENT TO MONTELUKAST 10 MG, LEVOCETIRIZIN HYDROCHLORIDE 5 MG) SERIES 05240279 - 8 600UP. CANDID, SOLUTION FOR EXTERNAL USE, 10 MG/1 ML, 20 ML IN A CAP WITH A PER WHEN OPENING: 1 VIAL IN A CARDBOARD PACKAGING (EXPIRED INGREDIENTS - 100 ML OF SOLUTION CONTAINS CLOTRIMAZOLE 1G) SERIES 10240303- 360UP.ONABET, CREAM 20 MG/G, 20 G IN A TUBE, 1 TUBE IN A CARTON PACKAGING (ACTIVE INGREDIENTS - 1 G OF CREAM CONTAINS SERTACONAZOLE NITRATE 20 MG) SERIES 10240489- 11 712 UP. TRADEMARK: GLENMARK COUNTRY OF PRODUCTION: IN MANUFACTURER: GLENMARK PHARMACEUTICALS LTD | |
|
INDIA | UKRAINE | 0 |
| 3004900000 | 1. HUMAN MEDICINES FOR THERAPEUTIC USE, PACKAGED FOR RETAIL: GLEMONT CHEWABLE TABLETS, 4 MG CHEWABLE TABLETS; 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 TABLET CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 4 MG) SERIES 05240418 - 3 540UP. GLEMONT CHEWABLE TABLETS, TABLET KI CHEWABLE 5 MG; 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 TABLET CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 5 MG) SERIES 05240419 - 3 460 TRADEMARK: GLENMARK COUNTRY OF MANUFACTURE COMPANY: IN MANUFACTURER: GLENMARK PHARMACEUTICALS LTD | |
|
INDIA | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, FOR THERAPEUTIC USE, PACKAGED FOR RETAIL SALE: CANDID, SOLUTION FOR THE ORAL CAVITY 1% OF 15 ML IN A BOTTLE WITH A STOPPER-DROPPER AND A CAP WITH CONTROL OF THE FIRST OPENING; 1 VIAL IN A CARDBOARD PACKAGE (ACTIVE SUBSTANCES - 1 ML OF SOLUTION CONTAINS CLOTRIMAZOLE 10 MG) SERIES 10232309- 360 PACK. GLEMONT CHEWABLE TABLETS, 4 MG CHEWABLE TABLETS; 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 4 MG) SERIES 05231029 - 480 UNITS. TRADE MARK: GLENMARK MANUFACTURER: GLENMARK PHARMACEUTICALS LTD. COUNTRY OF MANUFACTURE: IN | |
|
INDIA | UKRAINE | 0 |
| 3004900000 | 1. HUMAN MEDICINES FOR THERAPEUTIC USE, PACKAGED FOR RETAIL TRADE: ASCORIL EXPECTORANT, SYRUP; 100 ML PLASTIC VIALS; 1 VIAL TOGETHER WITH A MEASURING CAP IN A CARTON PACKAGING (ACTIVE INGREDIENTS: 10 ML OF SYRUP CONTAINS SALBUTAMOL SULFATE EQUIVALENT TO 2 MG OF SALBUTAMOL, 4 MG OF BROMHEXINE HYDROCHLORIDE, 100 MG OF MENTHOL MG) SERIES 10232613- 49 280UP. CANDID, SKIN POWDER, 10 MG/ G BY 30 G IN A BOTTLE; 1 VIAL IN A CARTON BOX (ACTIVE INGREDIENTS - 1 G OF POWDER CONTAINS CLOTRIMAZOLE 10 MG) SERIES 10233023 - 10 286UP. CANDID, SOLUTION FOR EXTERNAL USE, 10 MG/1 ML, 20 ML IN A VIAL WITH A CAP CONTROL OF THE FIRST OPENING: PO 1 VIAL IN A CARTON PACKAGING (ACTIVE INGREDIENTS - 100 ML OF SOLUTION CONTAINS CLOTRIMAZOLE 1 G) SERIES 10232983 - 4 470 UNITS OF DERIVATIVE WATER GEL, GEL, 1 MG/H FOR 15 G IN A TUBE; 1 TUBE IN A CARDBOARD BOX (ACTIVE INGREDIENTS - 1 G CONTAINS ADAPALENA 1 MG) SERIES 10233256 - 17 640UP.GLEMONT CHEWABLE TABLETS, CHEWABLE TABLETS OF 5 MG; 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 TABLET CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 5 MG) SERIES 05231727 - 2 460UP.GLEMONT CHEWABLE TABLETS, TABLET KI CHEWABLE 4 MG; 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 TABLET CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 4 MG) SERIES 05231726 - 3 360UP.KERAVORT, CREAM 5% PER 250 MG REMU IN SASHE; 12 SACHETS IN A CARDBOARD BOX (ACTIVE INGREDIENTS - 1 SACHET (250 MG CREAM) CONTAINS IMIQUIMOD 12.5 MG) SERIES 19234640- 3 020 TRADE BRAND: GLENMARK COUNTRY OF MANUFACTURE: IN MANUFACTURER: GLENMARK PHARMACEUTICALS LTD." | |
|
INDIA | UKRAINE | 0 |
| 3004900000 | 1. HUMAN MEDICINES FOR THERAPEUTIC USE, PACKAGED FOR RETAIL: GLEMONT CHEWABLE TABLETS, 5 MG CHEWABLE TABLETS; 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 TABLET CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 5 MG) SERIES 05231727 - 960 UP. GLEMONT CHEWABLE TABLETS, CHEWABLE TABLETS FLAX 4 MG; 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 TABLET CONTAINS MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 4 MG) SERIES 05231726 - 160UP. CANDID, SKIN POWDER, 10 MG/ G BY 30 G IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE INGREDIENTS - 1 G OF POWDER CONTAINS CLOTRIMAZOLE 10 MG) SERIES 10233023 - 945UP.GLENCET, COATED TABLETS, 5 MG, 10 TABLETS IN A BLISTER; 3 BLISTERS IN CARTON (ACTIVE SUBSTANCES - 1 TABLET CONTAINS LEVOCETHYRIZINE DIHYDROCHLORIDE 5 MG) SERIES 19234227 - 504PRIVILLE BRAND: GLENMARK PRODUCTION OF PRODUCTION: IN PRODUCER: GLENMARK PHARMACEUTICALZ LTDD | |
|
INDIA | UKRAINE | 0 |
| 300680 | PHARMACEUTICALS DERIVA GEL 30GM GLEMONT - L T | |
|
IN, INDIA | USA | 12 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Products Glemont export markets
Discover Products Glemont with data on monthly export values, major exporting countries, key ports, leading competitors, and active buyers.
TOP EXPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 30049029 | 1.91 | 95 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049099 | 0.88 | 80 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049039 | 0.68 | 22 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049090 | 0.09 | 4 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 85389000 | 0.02 | 3 | 0.00 |
| PARTS SUITABLE FOR USE SOLELY OR PRINCIPALLY WITH THE APPARATUS OF HEADINGS 8535, 8536 OR 8537 | |||
TOP EXPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| KENYA | 0.56 | 19 | 0.00 |
| COLOMBIA | 0.46 | 12 | 0.00 |
| SRI LANKA | 0.34 | 42 | 0.00 |
| MALDIVES | 0.31 | 18 | 0.00 |
| MALAYSIA | 0.29 | 10 | 0.00 |
TOP EXPORT PORTS
| PORTS | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| NHAVA SHEVA SEA | 2.01 | 135 | 0.00 |
| BOMBAY AIR CARGO | 0.72 | 43 | 0.00 |
| DELHI AIR CARGO | 0.58 | 18 | 0.00 |
| NEW YORK-JOHN F. KENNEDY APT | 0.00 | 5 | 0.00 |
| HYDERABAD AIR CARGO | 0.11 | 3 | 0.00 |
TOP EXPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| MODERN INNOVATION PRIVATE LIMITED | 0.03 | 7 |
| MEDIPAC INTERNATIONAL PRIVATE LIMITED | 0.07 | 1 |
| ABB INDIA LIMITED | 0.02 | 5072 |
| CAJAEXPRESS COURIER S A | 0.00 | 295 |
| GLENMARK PHARMACEUTICALS LIMITED | 3.49 | 12566 |
TOP EXPORT BUYERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| GLENMARK PHARMACEUTICALS COLOMBIA S | 0.46 | 23 |
| GLENMARK UKRAINE LLC | 0.24 | 38 |
| GLENMARK PHARMACEUTICALS KENYA LIMITED | 0.42 | 223 |
| ABACUS PHARMA A LIMITED | 0.22 | 733 |
| GLENMARK PHARMACEUTICALS ECUADOR S | 0.26 | 47 |
Access the complete database of 41 buyers and 12 suppliers with a one-time subscription plan.
Glemont Export Market
Analyze HSN Code Glemont with product description, export values, quantities, importer name, country of origin and key import destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30049029 | GLEMONT - L TABLET 14S | |
|
INDIA | DOMINICAN REPUBLIC | 1280 |
| 30049029 | GLEMONT - L TABLET 14S ( 640 CON ) PHYSICIAN SAMPLE / FOC / FREE GOODS OF NO COMMERCIAL VALUE (GR WAIVER -MHL/FOREX/PK | |
|
INDIA | DOMINICAN REPUBLIC | 0.01 |
| 30049029 | GLEMONT CT 5 TABLETS 3X10'S | |
|
INDIA | DOMINICAN REPUBLIC | 800 |
| 30049029 | GLEMONT CT 4 TABLETS 3X10'S, QTY: 53 CAR (FOC), GR WAIVER NO. ANLCB/FE/HK/24-25/000464 DT.17.08.2024 | |
|
INDIA | DOMINICAN REPUBLIC | 1 |
| 30049029 | GLEMONT CT 4 TABLETS 3X10'S | |
|
INDIA | DOMINICAN REPUBLIC | 267 |
| 30049029 | GLEMONT CT 5 TABLETS 3X10'S, QTY: 160 CAR (FOC ) | |
|
INDIA | DOMINICAN REPUBLIC | 1 |
| 30049029 | GLEMONT CT 4 TABLETS 3X10'S, QTY: 53 CAR (FOC) | |
|
INDIA | DOMINICAN REPUBLIC | 1 |
| 30049029 | GLEMONT CT 5 TABLETS 3X10'S | |
|
INDIA | DOMINICAN REPUBLIC | 800 |
| 30049029 | GLEMONT CT 4 TABLETS 3X10'S | |
|
INDIA | DOMINICAN REPUBLIC | 267 |
| 30049029 | GLEMONT CT 5 TABLETS 3X10'S, QTY: 160 CAR (FOC ), GR WAIVER NO. ANLCB/FE/HK/24-25/000464 DT.17.08.2024 | |
|
INDIA | DOMINICAN REPUBLIC | 1 |
| 30049029 | GLEMONT IR 10MG 3X10S | |
|
INDIA | DOMINICAN REPUBLIC | 1029 |
| 30049029 | PHYSICIAN SAMPLE / FOC / FREE GOODS OF NO COMMERCIAL VALUE (GR WAIVER NO. MHL/FOREX/PK/2023-24/37 DT. 22.03.2024)GLEMONT | |
|
INDIA | DOMINICAN REPUBLIC | 557 |
| 30049029 | PHYSICIAN SAMPLE / FOC / FREE GOODS OF NO COMMERCIAL VALUE (GR WAIVER NO. MHL/FOREX/PK/2023-24/37 DT. 22.03.2024)GLEMONT | |
|
INDIA | DOMINICAN REPUBLIC | 411 |
| 30049029 | GLEMONT CT 4 TABLETS 3X10S | |
|
INDIA | DOMINICAN REPUBLIC | 883 |
| 9807209090 | BRONCHO-VAXOM FOR INFLAMMATION. BINOZYT FOR PHLEGM, ADECIL VITAMINS, TRIGEL BETA FOR THE GARGANTE, GLEMONT L FOR THE GARGANTE, COOKIES | |
|
EQUADOR | UNITED STATES | 1 |
| 9807209090 | 1 BIODERMA LIQUID DEMATOLOGICAL SOAP, 1 FINALIN HEADACHE, 1 BACTRIM FORTE INFECTION, 2 BETAZOL SCALP, 2 GLEMONT L DERMATOLOGICAL TREATMENT 1 DAIVOBET TOPICAL USE ON SCALP 6 HANDMADE CANDY | |
|
EQUADOR | UNITED STATES | 1 |
| 42021290 | BAGPACK FOR UGANDA (ASCORIL / GLEMONT L)COO INDIA BRAND VICTORIA CROSS | |
|
INDIA | KENYA | 268 |
| 90189099 | TONGUE DEPRESSOR ( ASCORIL, GLEMONT L ) | |
|
INDIA | KENYA | 700 |
| 90189099 | TONGUE DEPRESSOR ( ASCORIL, GLEMONT L ) | |
|
INDIA | KENYA | 700 |
Why should you choose Eximpedia?
Deep-Analysis Report
Get reports on market trends, price, volume, HS Code supply, product details, country of origin, number of buyers & suppliers, and total shipments with Eximpedia's deep analysis reports.
Access Database Across 130+ Countries
Gain statistical and analytical reports, competitors' shipment records, and country-specific data from over 130 countries.
20 types of unique dashboards
Eximpedia offers 20 types of unique dashboards, tailored to meet diverse business needs. From trade insights to buyer analysis, each dashboard delivers actionable data at your fingertips.
Effortless Global Buyer Discovery
Explore international markets with ease! Access over 5 billion records to identify buyers in 130+ countries with just a click.
Supplier Stability Monitor
Leverage historical shipment data and real-time alerts for a complete view of supplier reliability and performance.
Competitor Pricing Strategy Intelligence
Utilise our data-driven platform to uncover competitors’ pricing strategies and track market pricing trends.
Glemont frequently asked questions
The Glemont export-import data is sourced from verified trade records, ensuring high reliability and accuracy.
Eximpedia's data-driven platform allows you to analyze more than 130 countries worldwide and determine Glemont export-import statistics by country.
The data is updated regularly to reflect the latest trade trends and activities in the Glemont market.
Glemont trade data offers details on import-export volumes, top trading countries, key ports, leading competitors, and active suppliers.
Yes, advanced filters allow you to customize Glemont trade data based on region, buyers, shipment details, and more.